Article content
Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19
NEUCHATEL, Switzerland â Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in
Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).
1 To gauge the impact, the researchers used the Masimo Root
® Patient Monitoring and Connectivity Platform with O3
® Regional Oximetry, which uses near-infrared spectroscopy (NIRS) to enable monitoring of tissue oxygen saturation (rSO